These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 21881823)
1. Quantification of plasma Epstein-Barr virus DNA for assessing treatment response in a patient with plasmablastic lymphoma. Law MF; Poon WL; Ng KS; Chan HN; Lai HK; Ha CY; Ng C; Yeung YM; Yip SF Ann Hematol; 2012 May; 91(5):789-791. PubMed ID: 21881823 [No Abstract] [Full Text] [Related]
2. Can a blood test monitor lymphoma? Jones K; Gandhi MK Leuk Lymphoma; 2010 Jun; 51(6):957-9. PubMed ID: 20536342 [No Abstract] [Full Text] [Related]
3. Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma. Yoshino T; Nakamura S; Matsuno Y; Ochiai A; Yokoi T; Kitadai Y; Suzumiya J; Tobinai K; Kobayashi Y; Oda I; Mera K; Ohtsu A; Ishikura S Cancer Sci; 2006 Feb; 97(2):163-6. PubMed ID: 16441428 [TBL] [Abstract][Full Text] [Related]
4. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Machado AS; Da Silva Robaina MC; Magalhães De Rezende LM; Apa AG; Amoêdo ND; Bacchi CE; Klumb CE Leuk Lymphoma; 2010 Jun; 51(6):1020-7. PubMed ID: 20470219 [TBL] [Abstract][Full Text] [Related]
5. Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma. Tisi MC; Cupelli E; Santangelo R; Maiolo E; Alma E; Giachelia M; Martini M; Bellesi S; D'Alò F; Voso MT; Pompili M; Leone G; Larocca LM; Hohaus S Leuk Lymphoma; 2016; 57(3):628-34. PubMed ID: 26458141 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy. Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915 [No Abstract] [Full Text] [Related]
7. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma. Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764 [No Abstract] [Full Text] [Related]
8. Chronic active Epstein-Barr virus infection of T-cell type, systemic form in an African migrant: case report and review of the literature on diagnostics standards and therapeutic options. Wass M; Bauer M; Pfannes R; Lorenz K; Odparlik A; Müller LP; Wickenhauser C BMC Cancer; 2018 Oct; 18(1):941. PubMed ID: 30285657 [TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey. Ozsan N; Cagirgan S; Saydam G; Gunes A; Hekimgil M Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928 [TBL] [Abstract][Full Text] [Related]
10. Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy. Ahn JS; Yang DH; Duk Choi Y; Jung SH; Yhim HY; Kwak JY; Sung Park H; Shin MG; Kim YK; Kim HJ; Lee JJ Am J Hematol; 2013 Sep; 88(9):774-9. PubMed ID: 23760676 [TBL] [Abstract][Full Text] [Related]
11. Hemophagocytic syndrome in ileum-origin B-cell lymphoma. Motegi S; Nishizaki Y; Muramatsu C; Nakamura H; Kobayashi F; Shiozawa H; Kamochi J; Itakura M; Shibuya M; Ogawa T; Matsuzaki S J Gastroenterol; 2003; 38(10):995-9. PubMed ID: 14614609 [TBL] [Abstract][Full Text] [Related]
13. High efficacy of combined rituximab and gemcitabine on Epstein-Barr virus-associated human B-cell lymphoma obtained after Hodgkin's xenograft in immunodeficient mice. Decaudin D; Marszak FB; Couturier J; Mathiot C; Martin A; Némati F; Lantz O; Santo Jd; Arnaud P; Bordier V; Vincent-Salomon A; Poupon MF Anticancer Drugs; 2006 Jul; 17(6):685-95. PubMed ID: 16917214 [TBL] [Abstract][Full Text] [Related]
14. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case]. Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162 [No Abstract] [Full Text] [Related]
15. Methotrexate-induced and Epstein-Barr virus-associated B-cell lymphoma of the spine: MR and PET/CT imaging. Nguyen BD; Roarke MC; McCullough AE Clin Nucl Med; 2008 Mar; 33(3):208-10. PubMed ID: 18287849 [No Abstract] [Full Text] [Related]
16. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases. Tomoka T; Powers E; van der Gronde T; Amuquandoh A; Dhungel BM; Kampani C; Kamiza S; Montgomery ND; Fedoriw Y; Gopal S BMC Cancer; 2017 Sep; 17(1):633. PubMed ID: 28877678 [TBL] [Abstract][Full Text] [Related]
17. A tip of the iceberg: Disseminated plasmablastic lymphoma, diagnosed from a local oral lesion. Ke YL; Hsiao HH; Cho SF; Wu CC Kaohsiung J Med Sci; 2021 Apr; 37(4):346-347. PubMed ID: 33340392 [No Abstract] [Full Text] [Related]
18. Cutaneous precursor B-cell lymphoblastic lymphoma in association with Epstein-Barr virus. Alhaji M; Sadikot RT Am J Dermatopathol; 2011 Aug; 33(6):608-10. PubMed ID: 21778833 [TBL] [Abstract][Full Text] [Related]
19. The role of rituximab in a case of EBV-related lymphoproliferative disease presenting with haemophagocytosis. Bosman G; Langemeijer SM; Hebeda KM; Raemaekers JM; Pickkers P; van der Velden WJ Neth J Med; 2009 Sep; 67(8):364-5. PubMed ID: 19767670 [No Abstract] [Full Text] [Related]
20. Clinical and pathological aspects of human immunodeficiency virus-associated plasmablastic lymphoma: analysis of 24 cases. Koizumi Y; Uehira T; Ota Y; Ogawa Y; Yajima K; Tanuma J; Yotsumoto M; Hagiwara S; Ikegaya S; Watanabe D; Minamiguchi H; Hodohara K; Murotani K; Mikamo H; Wada H; Ajisawa A; Shirasaka T; Nagai H; Kodama Y; Hishima T; Mochizuki M; Katano H; Okada S Int J Hematol; 2016 Dec; 104(6):669-681. PubMed ID: 27604616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]